Growing community of inventors

Portland, OR, United States of America

Robert Copenhaver

Average Co-Inventor Count = 8.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 29

Robert CopenhaverSanjaya Singh (4 patents)Robert CopenhaverKeith Allen Canada (4 patents)Robert CopenhaverRachel Rebecca Barrett (3 patents)Robert CopenhaverXiangyang Zhu (3 patents)Robert CopenhaverKatrina Mary Catron (3 patents)Robert CopenhaverLee Edward Frego (3 patents)Robert CopenhaverErnest Lee Raymond (3 patents)Robert CopenhaverNorbert Hauel (1 patent)Robert CopenhaverChristopher Ronald Sarko (1 patent)Robert CopenhaverAlisa K Waterman (1 patent)Robert CopenhaverTobias Litzenburger (1 patent)Robert CopenhaverJoanne Van Ryn (1 patent)Robert CopenhaverKeith Canada (1 patent)Robert CopenhaverXiangyang Zhu (1 patent)Robert CopenhaverRobert Copenhaver (4 patents)Sanjaya SinghSanjaya Singh (69 patents)Keith Allen CanadaKeith Allen Canada (22 patents)Rachel Rebecca BarrettRachel Rebecca Barrett (13 patents)Xiangyang ZhuXiangyang Zhu (3 patents)Katrina Mary CatronKatrina Mary Catron (3 patents)Lee Edward FregoLee Edward Frego (3 patents)Ernest Lee RaymondErnest Lee Raymond (3 patents)Norbert HauelNorbert Hauel (86 patents)Christopher Ronald SarkoChristopher Ronald Sarko (19 patents)Alisa K WatermanAlisa K Waterman (12 patents)Tobias LitzenburgerTobias Litzenburger (9 patents)Joanne Van RynJoanne Van Ryn (4 patents)Keith CanadaKeith Canada (3 patents)Xiangyang ZhuXiangyang Zhu (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Boehringer Ingelheim International Gmbh (4 from 1,537 patents)


4 patents:

1. 10202448 - Anti-IL-23 antibodies

2. 9441036 - Anti-IL-23 antibodies

3. 8821871 - Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereof

4. 8778346 - Anti-IL-23 antibodies

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/13/2026
Loading…